OBJECTIVE
To determine the incidence and risk factors for neurodevelopmental impairment (NDI) in children with hemolytic disease of the fetus/newborn treated with intrauterine transfusion (IUT).
METHODS
Neurodevelopmental outcome in children at least 2 years of age was assessed using standardized